Xeljanz XR Alternatives Compared
Xeljanz XR | Otezla | Upadacitinib |
|
---|
Xeljanz XR (tofacitinib) | Otezla (apremilast) | Upadacitinib |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis, Ulcerative Colitis. Xeljanz XR may also be used for purposes not listed in this medication guide. |
Prescription only
Otezla is a PDE4 inhibitor that may be used to treat plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet’s Disease. It has been associated with severe diarrhea, nausea, and v... View more |
Prescription only
Prescribed for Crohn's Disease, Ankylosing Spondylitis, Atopic Dermatitis, Non-Radiographic Axial Spondyloarthritis, Polyarticular Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Rheumatoid... View more |
Related suggestions Psoriatic Arthritis
|
|||||||||||||||
More about Xeljanz XR (tofacitinib) | More about Otezla (apremilast) | More about Upadacitinib | ||||||||||||||||
Ratings & Reviews | ||||||||||||||||||
Xeljanz XR has an average rating of 6.1 out of 10 from a total of 17 ratings on Drugs.com. 56% of reviewers reported a positive effect, while 38% reported a negative effect. |
Otezla has an average rating of 5.1 out of 10 from a total of 429 ratings on Drugs.com. 34% of reviewers reported a positive effect, while 42% reported a negative effect. |
Upadacitinib has an average rating of 6.7 out of 10 from a total of 175 ratings on Drugs.com. 53% of reviewers reported a positive effect, while 24% reported a negative effect. |
||||||||||||||||
Drug Class | ||||||||||||||||||
Side Effects | ||||||||||||||||||
See also: Xeljanz XR side effects in more detail. |
See also: Otezla side effects in more detail. |
See also: upadacitinib side effects in more detail. |
||||||||||||||||
Generic Availability | ||||||||||||||||||
N/A |
||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
View all Xeljanz XR prices |
View all Otezla prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||||||||||
Dosage Form(s) Available | ||||||||||||||||||
|
|
N/A |
||||||||||||||||
Brand Names | ||||||||||||||||||
Other tofacitinib brands include: Xeljanz, Xeljanz Oral Solution |
N/A |
Rinvoq, Rinvoq LQ | ||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
3 hours |
9 hours |
14 hours |
||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | ||||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | ||||||||||||||||||
A total of 602 drugs are known to interact with Xeljanz XR:
|
A total of 86 drugs are known to interact with Otezla:
|
A total of 550 drugs are known to interact with upadacitinib:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions | ||||||||||||||||||
First Approval Date | ||||||||||||||||||
February 23, 2016 |
March 21, 2014 |
August 16, 2019 |
||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
More Information | ||||||||||||||||||
Patient resources | ||||||||||||||||||
Professional Resources | ||||||||||||||||||
N/A |
||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.